Kariya Pharmaceuticals

Kariya Pharmaceuticals is a biotechnology company dedicated to developing innovative disease-modifying agents to treat neurodegenerative diseases such as Parkinson's and Alzheimer's. Kariya has developed KP405, a dual incretin receptor co-agonist that helps slow the progression of Parkinson's disease.